Human peripheral blood‑derived exosomes for microRNA delivery

Area of Science:

• Cardiovascular Biology
• Cellular and Molecular Medicine
• Biotechnology

Background:

• Exosomes mediate cell-to-cell communication by shuttling molecules.
• MicroRNAs (miRNAs) hold therapeutic potential for cardiac diseases, but effective delivery is crucial.
• Myocardial infarction (MI) leads to cardiac remodeling and fibrosis.

Purpose of the Study:

• To investigate human peripheral blood-derived exosomes as a delivery system for miRNAs.
• To determine if exosome-mediated delivery of miR-21 impacts cardiac remodeling after MI.
• To assess the therapeutic efficacy of exosome-delivered miR-21 in a mouse MI model.

Main Methods:

• Loading human peripheral blood exosomes with miR-21 mimics or inhibitors.
• Treating H9C2 and HL-1 cells with exosome-miRNA complexes to assess miRNA regulation.
• Analyzing mRNA and protein expression of fibrosis-related genes (Smad7, PTEN, MMP2) in vitro and in vivo.
• Evaluating cardiac fibrosis in a mouse MI model following exosome-miRNA treatment.

Main Results:

• Exosomes successfully delivered miR-21 mimics/inhibitors into cells, regulating miR-21 expression.
• Uptake of exosome-loaded miRNAs altered the expression of Smad7, PTEN, and MMP2 in vitro and in vivo.
• miR-21 mimic-loaded exosomes exacerbated cardiac fibrosis, while inhibitor-loaded exosomes reduced it in the mouse MI model.

Conclusions:

• Human peripheral blood-derived exosomes are effective carriers for miRNA delivery.
• Exosome-mediated miR-21 delivery can modulate cardiac fibrosis.
• miRNA-loaded exosomes represent a promising therapeutic strategy for managing cardiac remodeling post-MI.